Fanglin Niu

1.3k total citations · 1 hit paper
38 papers, 882 citations indexed

About

Fanglin Niu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Fanglin Niu has authored 38 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Fanglin Niu's work include Cancer-related molecular mechanisms research (9 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Drug Transport and Resistance Mechanisms (7 papers). Fanglin Niu is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Drug Transport and Resistance Mechanisms (7 papers). Fanglin Niu collaborates with scholars based in China and United States. Fanglin Niu's co-authors include Qian Lü, Yi Yu, Yuyan Xiong, Xiling Zhao, Xueyi Chen, Yan Yuan, Yuru Liu, Yajun Wang, Ping Liu and Yuanyuan Ren and has published in prestigious journals such as Gene, Biochemical Pharmacology and Medicine.

In The Last Decade

Fanglin Niu

37 papers receiving 874 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases

2021 518 citations Yi Yu, Fanglin Niu et al. profile →

Peers

Fanglin Niu

MB

PRM

CR

IMMUN

ONCOL

Yi Yu China

Jinzhuo Ning China

Christudas Morais Australia

Zhanyu Wang China

Harold J. Ting United States

Wenqian Zhou China

Jiaming Xie China

Pablo Cannata Spain

Zhaowei Wen China

Yi Yu China

Fanglin Niu

584 ×1.4

MB

355 ×1.1

PRM

297 ×1.0

CR

117 ×1.0

IMMUN

112 ×1.1

ONCOL

Citations per year, relative to Fanglin Niu Fanglin Niu (= 1×) peers Yi Yu

Countries citing papers authored by Fanglin Niu

Since Specialization

Citations

This map shows the geographic impact of Fanglin Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanglin Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanglin Niu more than expected).

Fields of papers citing papers by Fanglin Niu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanglin Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanglin Niu. The network helps show where Fanglin Niu may publish in the future.

Co-authorship network of co-authors of Fanglin Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Fanglin Niu. A scholar is included among the top collaborators of Fanglin Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanglin Niu. Fanglin Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Niu, Fanglin, Yuanyuan Ren, Yang Li, et al.. (2025). RNA-binding protein GIGYF2 promotes colorectal cancer progression through activation of the METTL3/SERP1/STAT3 axis in an m6A-IGF2BP2-dependent manner. Biochemical Pharmacology. 243(Pt 1). 117446–117446.

2.

Li, Yang, Fanglin Niu, Zhuozhuo Li, et al.. (2024). RNA-binding protein GIGYF2 orchestrates hepatic insulin resistance through STAU1/PTEN-mediated disruption of the PI3K/AKT signaling cascade. Molecular Medicine. 30(1). 124–124. 7 indexed citations

3.

Niu, Fanglin, Wenxuan Liu, Yuanyuan Ren, et al.. (2023). β-cell neogenesis: A rising star to rescue diabetes mellitus. Journal of Advanced Research. 62. 71–89. 21 indexed citations

4.

Niu, Fanglin, Zhuozhuo Li, Yuanyuan Ren, et al.. (2023). Aberrant hyper-expression of the RNA binding protein GIGYF2 in endothelial cells modulates vascular aging and function. Redox Biology. 65. 102824–102824. 12 indexed citations

5.

Niu, Fanglin, Yi Yu, Zhuozhuo Li, et al.. (2022). Arginase: An emerging and promising therapeutic target for cancer treatment. Biomedicine & Pharmacotherapy. 149. 112840–112840. 103 indexed citations

6.

Yu, Yi, Yuanyuan Ren, Caihua Wang, et al.. (2022). Arginase 2 negatively regulates sorafenib-induced cell death by mediating ferroptosis in melanoma. Acta Biochimica et Biophysica Sinica. 54(11). 1658–1670. 11 indexed citations

7.

Wu, Jia‐Min, Yao Sun, Fanglin Niu, et al.. (2020). Influence of CMTM8 polymorphisms on lung cancer susceptibility in the Chinese Han population. Pharmacogenetics and Genomics. 31(4). 89–95. 1 indexed citations

8.

Tian, Yu, Yao Sun, Jia‐Min Wu, et al.. (2020). Impact of IL1R1 polymorphisms on the risk of head and neck cancer in Chinese Han population. Gene. 757. 144927–144927. 3 indexed citations

9.

Liu, Yuanwei, Haiyue Li, Jianfeng Liu, et al.. (2020). Genetic variation of pharmacogenomic VIP variants in Zhuang nationality of southern China. The Pharmacogenomics Journal. 21(1). 60–68. 6 indexed citations

10.

Chen, Qu, et al.. (2019). LPP and RYR2 Gene Polymorphisms Correlate with the Risk and the Prognosis of Astrocytoma. Journal of Molecular Neuroscience. 69(4). 628–635. 7 indexed citations

11.

Gao, Ning, et al.. (2019). Association of the MMP-9 polymorphism and ischemic stroke risk in southern Chinese Han population. BMC Neurology. 19(1). 67–67. 12 indexed citations

12.

Wu, Jia‐Min, et al.. (2019). Genetic polymorphisms in IL1B predict susceptibility to steroid-induced osteonecrosis of the femoral head in Chinese Han population. Osteoporosis International. 30(4). 871–877. 16 indexed citations

13.

Sun, Rong, Shan Wu, Tianbo Jin, et al.. (2019). Single nucleotide polymorphism in the 3′ untranslated region of LPP is a risk factor for lung cancer: a case-control study. BMC Cancer. 19(1). 35–35. 9 indexed citations

14.

Niu, Fanglin, et al.. (2018). Matrix metalloproteinase-2 gene polymorphisms are associated with ischemic stroke in a Hainan population. Medicine. 97(39). e12302–e12302. 7 indexed citations

15.

He, Yongjun, Fanglin Niu, Mengdan Yan, et al.. (2018). Polymorphisms of drug-metabolizing enzyme CYP2E1 in Chinese Uygur population. Medicine. 97(7). e9970–e9970. 6 indexed citations

16.

Yan, Mengdan, Jing Li, Fanglin Niu, et al.. (2018). Genetic polymorphisms of pharmacogenomic VIP variants in the Yi population from China. Gene. 648. 54–62. 8 indexed citations

17.

Li, Jing, Chenghao Guo, Mengdan Yan, et al.. (2018). Genetic polymorphisms in very important pharmacogenomic variants in the Zhuang ethnic group of Southwestern China. Medicine. 97(17). e0559–e0559. 3 indexed citations

18.

Wang, Li, Jingjie Li, Fanglin Niu, et al.. (2017). Genetic polymorphism analysis of cytochrome P4502E1 (CYP2E1) in a Chinese Tibetan population. Medicine. 96(47). e8855–e8855. 8 indexed citations

19.

Li, Shunan, et al.. (2017). Association between IL4, IL6 gene polymorphism and lumbar disc degeneration in Chinese population. Oncotarget. 8(51). 89064–89071. 8 indexed citations

20.

Niu, Fanglin, et al.. (2017). Polymorphisms of telomere-length related genes in three China ethnic groups.. PubMed. 10(9). 9654–9665. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact